The underlying neuropathology of AD includes extracellular deposition of amyloid β-peptide (Aβ) and intra-neuronal accumulation of hyperphosphorylated tau forms [1, 2], as well as synapse dysfunction and neuronal loss [2–5]. Here, MAPT is linked to Alzheimer disease.